menu Search
Praxbind

Praxbind Caution For Usage

idarucizumab

Manufacturer:

Boehringer Ingelheim

Distributor:

Metro Drug

Marketer:

Boehringer Ingelheim
Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Side Effects Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Caution For Usage
Incompatibilities: This medicinal product must not be mixed with other medicinal products.
Special precautions for disposal and other handling: Parenteral medicinal products such as Idarucizumab (Praxbind) should be inspected visually for particulate matter and discoloration prior to administration.
Idarucizumab (Praxbind) must not be mixed with other medicinal products. A pre-existing intravenous line may be used for administration of Idarucizumab (Praxbind). The line must be flushed with sodium chloride 9 mg/ml (0.9 %) solution for injection prior to and at the end of infusion. No other infusion should be administered in parallel via the same intravenous access.
Idarucizumab (Praxbind) is for single-use only and does not contain preservatives.
No incompatibilities between Idarucizumab (Praxbind) and polyvinyl chloride, polyethylene or polyurethane infusion sets or polypropylene syringes have been observed.